NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the development and commercialization of small molecule drugs and recombinant proteins.

Recs

0
Player Avatar pchop123 (80.37) Submitted: 4/5/2013 11:30:43 AM : Outperform Start Price: $10.85 NPSP Score: +9.22

speculating in positive direction now

Featured Broker Partners


Advertisement